SIRPA and neoplasm: A previous study by Cao et al. assessed the genetically engineered oncolytic vaccinia virus (VV) to express SIRPα-Fc (SIRPα-Fc-VV), which helps macrophages to secret this SIRPα and redirect the phagocytic property to control the tumor cell proliferation [93].